Analyst consensus rating
Voyager Therapeutics Analyst Rating: Strong Buy
Direct answer
Voyager Therapeutics's consensus rating is Strong Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $14.89.
Forecast evidence checked October 17, 2026.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.90
- Average price target
- $14.89
- High price target
- $25.00
- Low price target
- $8.00
- Low target gap
- +321.1%
- Target upside
- +683.6%
- High target gap
- +1,215.8%
- Target range width
- 894.7%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Voyager Therapeutics?
Voyager Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $14.89.
How far are Voyager Therapeutics's low and high targets from the recorded price?
The low target implies +321.1%, while the high target implies +1,215.8%.
How many analysts are included in Voyager Therapeutics's consensus?
The verified consensus includes 9 analysts.
How is Voyager Therapeutics's target upside or downside calculated?
The average target of $14.89 is divided by the recorded price of $1.90, then one is subtracted to produce +683.6%. This does not guarantee a future return.
When was Voyager Therapeutics's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.